TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks July 30, 1982